MeSH tree: D27.505.696
An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found that, among currently ...
23 hours ago
0
10
There is no link between the widely used diabetes and obesity medications known as GLP-1 receptor agonists and increased suicidal thoughts, depression or other serious psychiatric harm, based on an integrative review of current ...
Aug 31, 2026
0
9
Reflecting improved understanding and treatment advances, new European Society of Cardiology (ESC) guidelines on heart failure have been published online today in the European Heart Journal and will be presented at ESC Congress ...
Aug 30, 2026
0
9
The differences in male and female sex hormones are most evident during growth, puberty and reproduction, when they help shape how the body develops and functions. Beyond their more visible effects, these chemical messengers ...
Glucagon-like peptide 1 receptor agonists (GLP-1RA), commonly used to treat diabetes and weight loss, may have additional mental health benefits, especially for people with bipolar disorder, new Griffith University research ...
Aug 24, 2026
0
13
Researchers surveyed 114 sports medicine physicians from 38 countries, covering 93 different sports, to explore their views on athletes' use of GLP-1 drugs. Twelve percent said they were aware of athletes using the medications ...
Aug 20, 2026
0
10
Endocrine disruptors are compounds capable of altering the production, transport, metabolism or action of hormones. They are found in various everyday products, such as plastic containers, the inner linings of cans, food ...
Aug 18, 2026
0
4
A familiar song can bring back a memory from decades ago. A particular smell can recall a person or place. And a frightening memory can trigger a simultaneous emotional and physical response almost instantly. Computers, too, ...
Aug 18, 2026
0
19
Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair—the same puzzling symptoms that plagued her mom for decades and that no doctor could piece ...
Aug 16, 2026
0
9
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU's Pennington Biomedical Research Center and ...
Aug 14, 2026
0
1565
